Register Now

subject to change

November 2, 2018

8:00 AM
Registration and Continental Breakfast

8:30 AM
Welcome and Announcements
Judy Rein, Director, Publications, FDLI

8:40 – 9:30 AM
History and Overview of Cannabis Regulation

Presenters:	Erika Lietzan, Associate Professor, University of Missouri School of Law | Speaker’s Slides
	Lewis A. Grossman, Professor of Law, Washington College of Law, American University | Speaker’s Slides

9:30 – 10:20 AM
Canadian Liberalization and the Global Market

Presenter:

Patrick Moen, General Counsel, Privateer Holdings

10:20 – 10:30 AM
Networking and Coffee Break

10:30 – 11:45 AM
Edibles and Infused Products

Authors:	Deborah Shelton, Practice Group Leader, Food & Drug Law Practices, McCarter & English, LLP
	Daniel L. Flint, Ph.D Associate, McCarter & English, LLP | Speaker’s Slides
	“Points to Consider When Seeking Approval of Cannabis Edibles as Botanical Drugs”
	Kellsi Booth, Attorney, Wake Law Group (Los Angeles, CA)
	“The Mysteries of Medibles: Exploring the Regulation of Marijuana-Infused Products Intended for Medical Use”
Discussant:	James O’Reilly, University of Cincinnati | Speaker’s Slides
Moderator:	Daniel Dwyer, Partner, Kleinfeld Kaplan & Becker LLP

11:45 – 1:15 PM
Luncheon Keynote
Welcome: Amy Comstock Rick, President & CEO, FDLI
Aidan Hampson, Program Officer, Clinical Research Grants Branch, Division of Therapeutics & Medical Consequences, Special Content Expert on Cannabis, National Institute on Drug Abuse, National Institutes of Health | Speaker’s Slides
Introduced by Joseph A. Page, Professor Emeritus, Georgetown University Law Center and Faculty Advisor, Food and Drug Law Journal

1:15 – 2:30 PM
Medical Product Pathways

Authors:	Heike Newman, Senior Regulatory Manager, University of Colorado
	“Marijuana Research in Colorado 2018”
	Micha Mesure, Wake Law Group (Los Angeles, CA) | Speaker’s Slides
	“Using Foreign Data for Cannabis Derived Drug: Israel as a Guideline to Satisfy FDA Requirements and Comply with Federal Regulation”
Discussant:	Linda Bentley, Member, Mintz, Levin LLP
Moderator:	Sandra Retzky, Johns Hopkins University and FDA

2:30 – 2:45 PM
Networking and Coffee Break

2:45 – 4:15 PM
Strategies and Constraints for Moving Forward

Authors:	Srikumaran Melethil, Professor Emeritus, Schools of Pharmacy and Medicine, University of Missouri-Kansas City
	“State Regulation of the Commerce and Uses of Marijuana, a Federal Schedule I Drug”
	Tami Wahl, Principal, Tami L. Wahl | Speaker’s Slides
	“A Modern, Forward-Thinking State-Federal Framework”
	Eric Lindblom, Director, Tobacco Control and Food & Drug Law, O’Neill Institute for National & Global Health Law, Georgetown University Law Center
	“How FDA Could Use Its Existing Authorities to Make State Legalization of Cannabis for Medical or Broader Purposes More Safe and Effective”
Discussant:	Erica M. Jackson, Partner, K & L Gates LLP
Moderator:	Robert Giddings, Attorney, Hutchison PLLC and Chair, FDLI Editorial Advisory Board, Food and Drug Law Journal
Closing Remarks:	Amy Comstock Rick, President & CEO, FDLI

 

4:15 – 5:00 PM
FDLI Membership Meeting: Cannabis-Derived Products and Future Programming
FDLI invites Symposium participants to join FDLI members and staff in a brainstorming session led by FDLI President & CEO Amy Rick to share ideas for FDLI’s future engagement in this emerging area.

5:00 – 6:00 PM
Reception

 

 

FDLI applies for CLE credits in Ohio, Pennsylvania, and Virginia. These CLE approvals may also be honored by other states; please check with your bar association for guidance. The CLE credits will be posted as they are granted and you can request to be notified when approval is received.

Pennsylvania: approved for 5.5 CLE credit hours
Ohio: approved for 5.50 CLE credit hours